KIF1A

MAY 24, 2023

The central scientific goal for this class was to “[conduct] authentic research that studies the consequences of disease-related mutations in a neuronal kinesin (KIF1A), by using behavioral, genetic, and cell biological tools to assay how KIF1A mutations affect C. These are our future doctors. elegans neurons”. Our future scientists.

Disease 98

Disease Laboratories Research Science 98

Drug Target Review

JANUARY 31, 2024

Sara holds a bachelor’s degree in Pharmaceutical Sciences and a PhD in Pharmacology and Toxicology from the University of California, Irvine and completed her post-doctoral fellowship training in cardiovascular cell biology from the Lerner Research Institute at the Cleveland Clinic in Ohio.

Clinical Trials 97

Clinical Trials Production Science Research 97

Drug Target Review

JANUARY 30, 2024

About the author Dr Jia-Jia Zhang, Doctoral candidate Dr Jia-Jia Zhang is a doctoral candidate at the National Translational Science Center for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, and her research interest is the development of therapeutical antibodies to treat human disease.

Treatment 52

Treatment Doctors Cell Biology Regulations 52

Drug Target Review

MAY 21, 2024

As an undergraduate and as a doctoral candidate, I studied intestinal biology in a lab that used mostly animal models, because they were the only appropriate models that were available at the time. There were no relevant in vitro cell models available to answer the questions that we were asking.

Doctors 59

Doctors Science Research Cell Biology 59

Elrig

APRIL 29, 2024

She is currently a Senior drug discovery scientist working across Cell Engineering, Cell Biology and Functional Genomics teams, using CRISPR/Cas9 and Next Generation Sequencing for target identification, target validation and drug development in the oncology disease area.

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Codon

APRIL 9, 2024

After four years of a national effort to “ scientize Chinese medicine ” ( zhongyi kexuehua ), which designated Chinese doctors to study Western biomedicine, Mao Zedong reversed course in 1954, setting a new priority of “ Western doctors study Chinese medicine ( xiyi xuexi zhongyi ).” Nobody had an answer.

Drugs 138

Drugs Science Research Doctors 138

Broad Institute

OCTOBER 11, 2023

By Allessandra DiCorato October 11, 2023 In 2011, Robert Manguso was working in a cell biology lab when his mother was diagnosed with Merkel cell carcinoma, a rare and aggressive skin cancer. When I began my PhD I completely switched my focus, and I haven’t looked back,” said Manguso.

Research 137

Research Immune Response Clinical Trials Therapies 137